The U.S. Food and Drug Administration announced a request for information on October 5, 2026, seeking public feedback on early-phase clinical trial designs for ibogaine drug products.
Agree
Disagree
Overview
Debates
Related claims
Topics
Sources
From the article
US advances first government-funded trials of psychedelic drug ibogaine | Reuters
Also in
FDA Seeks Public Input to Support Ibogaine Research
5
52c7ae14
Article
US advances first government-funded trials of psychedelic drug ibogaine | Reuters
0
5
52c7ae14
Article
FDA Seeks Public Input to Support Ibogaine Research
0